全球范围内的卫生技术评估中的循证决策过程：探索卫生技术评估的下一个前沿和最佳实践 评“全球卫生技术评估机构使用循证决策过程”。
Evidence-Informed Deliberative Processes for HTA Around the Globe: Exploring the Next Frontiers of HTA and Best Practices Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe".
机构信息
Division for Health Services, Norwegian Institute of Public Health, Oslo, Norway.
Department of Community Medicine and Global Health, Institute of Health and Society, University of Oslo, Oslo, Norway.
出版信息
Int J Health Policy Manag. 2021 Mar 14;10(4):232-236. doi: 10.34172/ijhpm.2020.145.
Abstract
This comment reflects on an article by Oortwijn, Jansen, and Baltussen about the use and features of 'evidence-informed deliberative processes' (EDPs) among health technology assessment (HTA) agencies around the world and the need for more guidance. First, we highlight procedural aspects that are relevant across key steps of EDP, focusing on conflict of interest, the different roles of stakeholders throughout a HTA and public justification of decisions. Second, we discuss new knowledge and models needed to maximize the value of deliberative processes at the expanding frontiers of HTA, paying special attention to when HTA is applied in primary care, employed for public health interventions, and is produced through international collaboration.
摘要
这篇评论反思了 Oortwijn、Jansen 和 Baltussen 撰写的一篇文章，内容涉及全球卫生技术评估 (HTA) 机构使用和体现“循证审议过程” (EDP) 的情况，以及对更多指导意见的需求。首先，我们突出了 EDP 各关键步骤中相关的程序方面，重点讨论利益冲突、HTA 全过程中利益相关者的不同角色以及决策的公众论证。其次，我们讨论了在 HTA 的不断扩展前沿领域最大限度提高审议过程价值所需的新知识和模型，特别关注当 HTA 应用于初级保健、用于公共卫生干预措施以及通过国际合作产生时的情况。
相似文献
1
Evidence-Informed Deliberative Processes for HTA Around the Globe: Exploring the Next Frontiers of HTA and Best Practices Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe".全球范围内的卫生技术评估中的循证决策过程：探索卫生技术评估的下一个前沿和最佳实践 评“全球卫生技术评估机构使用循证决策过程”。
Int J Health Policy Manag. 2021 Mar 14;10(4):232-236. doi: 10.34172/ijhpm.2020.145.
2
Use of Evidence-Informed Deliberative Processes - Learning by Doing Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe".使用循证审议流程——在实践中学习 评论“全球卫生技术评估机构使用循证审议流程”。
Int J Health Policy Manag. 2020 Jun 1;9(6):263-265. doi: 10.15171/ijhpm.2019.116.
3
Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe.全球卫生技术评估机构对循证审议流程的使用。
Int J Health Policy Manag. 2020 Jan 1;9(1):27-33. doi: 10.15171/ijhpm.2019.72.
4
Deliberative Processes by Health Technology Assessment Agencies: A Reflection on Legitimacy, Values and Patient and Public Involvement Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe".卫生技术评估机构的审议程序：对合法性、价值观以及患者和公众参与的思考 评“全球卫生技术评估机构使用循证审议程序”。
Int J Health Policy Manag. 2021 Mar 14;10(4):228-231. doi: 10.34172/ijhpm.2020.46.
5
Evidence-Informed Deliberative Processes for Legitimate Health Benefit Package Design - Part I: Conceptual Framework.循证决策过程用于设计合理的健康福利套餐 - 第一部分：概念框架。
Int J Health Policy Manag. 2022 Oct 19;11(10):2319-2326. doi: 10.34172/ijhpm.2021.158. Epub 2021 Nov 10.
6
Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide.循证决策过程用于医疗福利套餐设计 - 第二部分：实用指南。
Int J Health Policy Manag. 2022 Oct 19;11(10):2327-2336. doi: 10.34172/ijhpm.2021.159. Epub 2021 Nov 10.
7
Evidence-Informed Deliberative Processes for UHC: Progress, Potential and Prudence Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide".基于循证的全民医保决策过程：进展、潜力与审慎——评“基于循证的卫生福利包设计决策过程：第二部分：实用指南”
Int J Health Policy Manag. 2023;12:7541. doi: 10.34172/ijhpm.2022.7541. Epub 2023 Feb 13.
8
HTA Agencies Need Evidence-Informed Deliberative Processes Comment on "Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe".HTA 机构需要证据为基础的审议程序 评论“全球卫生技术评估机构使用证据为基础的审议程序”。
Int J Health Policy Manag. 2021 Mar 1;10(3):158-161. doi: 10.34172/ijhpm.2020.22.
9
Value Assessment Frameworks for HTA Agencies: The Organization of Evidence-Informed Deliberative Processes.卫生技术评估机构的价值评估框架：循证审议过程的组织
Value Health. 2017 Feb;20(2):256-260. doi: 10.1016/j.jval.2016.11.019.
10
Three Approaches to Improve a Practical Guide on Evidence-Informed Deliberative Processes for Health Benefit Package Design Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide".三种方法改进健康福利套餐设计循证决策过程实用指南 述评：“健康福利套餐设计循证决策过程 - 第二部分：实用指南”
Int J Health Policy Manag. 2023;12:7502. doi: 10.34172/ijhpm.2022.7502. Epub 2022 Aug 31.
引用本文的文献
1
The Role of Medical Societies and the Relevance of Clinical Perspective in the Evolving EU HTA Process: Insights Generated at the 2023 Fall Convention and Survey of the European Access Academy.医学协会的作用以及临床视角在不断发展的欧盟卫生技术评估过程中的相关性：在2023年秋季大会及欧洲准入学会调查中获得的见解
J Mark Access Health Policy. 2024 Jun 22;12(3):128-143. doi: 10.3390/jmahp12030011. eCollection 2024 Sep.
本文引用的文献
1
Use of Evidence-Informed Deliberative Processes - Learning by Doing Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe".使用循证审议流程——在实践中学习 评论“全球卫生技术评估机构使用循证审议流程”。
Int J Health Policy Manag. 2020 Jun 1;9(6):263-265. doi: 10.15171/ijhpm.2019.116.
2
Promoting Intersectoral Collaboration Through the Evaluations of Public Health Interventions: Insights From Key Informants in 6 European Countries.通过公共卫生干预措施评估促进部门间协作：6 个欧洲国家关键知情人的见解。
Int J Health Policy Manag. 2021 Feb 1;10(2):67-76. doi: 10.34172/ijhpm.2020.19.
3
Harnessing the power of health taxes.利用健康税的力量。
BMJ. 2020 Jun 18;369:m1436. doi: 10.1136/bmj.m1436.
4
Institutionalizing Evidence-Informed Priority Setting for Universal Health Coverage: Lessons From Indonesia.将证据转化为优先事项，实现全民健康覆盖：来自印度尼西亚的经验。
Inquiry. 2020 Jan-Dec;57:46958020924920. doi: 10.1177/0046958020924920.
5
Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe.全球卫生技术评估机构对循证审议流程的使用。
Int J Health Policy Manag. 2020 Jan 1;9(1):27-33. doi: 10.15171/ijhpm.2019.72.
6
Implementing health technology assessment in Ghana to support universal health coverage: building relationships that focus on people, policy, and process.在加纳实施卫生技术评估以支持全民健康覆盖：建立关注人、政策和过程的关系。
Int J Technol Assess Health Care. 2020;36(1):8-11. doi: 10.1017/S0266462319000795. Epub 2019 Nov 28.
7
Health Technology Assessment of Public Health Interventions Published 2012 to 2016: An Analysis of Characteristics and Comparison of Methods.公共卫生干预措施的健康技术评估：2012 年至 2016 年发表的分析特征和方法比较。
Int J Technol Assess Health Care. 2019;35(4):280-290. doi: 10.1017/S0266462319000515. Epub 2019 Jul 24.
8
From the National Health Service to local government: perceptions of public health transition in England.从国民保健制度到地方政府：英格兰对公共卫生转型的看法。
Public Health. 2019 Sep;174:11-17. doi: 10.1016/j.puhe.2019.05.016. Epub 2019 Jun 29.
9
NICE, in Confidence: An Assessment of Redaction to Obscure Confidential Information in Single Technology Appraisals by the National Institute for Health and Care Excellence.NICE（英国国家卫生与临床优化研究所）：在保密中的评估——对英国国家卫生与临床优化研究所单一技术评估中掩盖保密信息的做法。
Pharmacoeconomics. 2019 Nov;37(11):1383-1390. doi: 10.1007/s40273-019-00818-0.
10
European Collaboration in Health Technology Assessment (HTA): goals, methods and outcomes with specific focus on medical devices.欧洲卫生技术评估合作项目：目标、方法及成果，特别聚焦于医疗设备
Wien Med Wochenschr. 2019 Sep;169(11-12):284-292. doi: 10.1007/s10354-019-0684-0. Epub 2019 Feb 6.
Zotero 插件